Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.57NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AH.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.365NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.223NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.640.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.11 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.428NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.355NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.34.1.1 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.71 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.33.2 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.52NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.465NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.160.33NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.4.2.5 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XFNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
S.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.221.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.258.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.215NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.36.20NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.82NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.462NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.218NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.443NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.595.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.495NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.294NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.453NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.44NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.350NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.304NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.315NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.516NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.354NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.162NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.426NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.402NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.424NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.61NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.264NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.581NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.330NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.205NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.177NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.301NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.308NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.210NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.325NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used